Developers are now working on new versions and improving the results of artificial intelligence.

Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...

WESTBOROUGH, Mass., January 09, 2025--eClinicalWorks®, the largest ambulatory cloud EHR, today announced that Clinica Medica ...